WELCOME TO VIVEBIO SCIENTIFIC
ViveBio is a biotechnology company focused on providing innovative, cost-effective, solutions in biological specimen collection and transportation that can make a quantifiable difference in people’s lives. These solutions will extend beyond incremental advances helping to change the paradigm of how healthcare is accessed and provided.
The Dried Plasma Separator
US Patent Issued 2020
Step 1
Finger prick with lancet.
Step 2
Apply 2 to 3 drops of blood.
Step 3
Allow plasma to dwell for 120 seconds.
Step 4
Separate cap (containing red/white blood cells and platelets) and block into receiver .
Step 5
Dried Plasma Separator ready to ship (20 ul).
Step 6
Insert dried plasma separator into foil pouch with desiccant.
Step 7
Seal foil pouch and ship to lab.
Measurements of Nutritional and Inflammatory Biomarkers in ViveBio Dry Plasma Separator
Real-Time Stability of Plasma Using ViveST, a Revolutionary Ambient Temperature, Storage and Transportation Device
HCV and HIV Testing using a novel dried ambient sample collection and transport device, ViveST
Detection of Low Level HCV RNA in Room Temperature Stored Samples Using ViveST, a Transformational Storage and Transport Device
Room Temperature Stable, Dry-Transport Technology For Molecular Diagnostic Controls
Proof of Concept: Novel Plasma Separation Cards for HCV/HIV Quantitation
Real-Time Stability of Plasma Using ViveST, a Revolutionary Ambient Temperature, Storage and Transportation Device
HCV and HIV testing using a Novel Dried Ambient Sample Collection and Transport Device, ViveST
Products
Our Sample Transportation and Storage System, DriVive™, is the first in a series of revolutionary, biological sample transport systems that will dramatically alter the way blood samples are transported.
How it Works
The DriVive™ system takes capillary blood then separates the plasma with its biomarkers from the whole blood in a unique and easy to use process. The samples can then be sent through standard postal system for testing.
About Us
We are a biotechnology company focused on providing innovative solutions that can make a quantifiable difference in people’s lives. These solutions will help change the paradigm of how healthcare is accessed and provided.
In the News
Emory Healthcare is currently validating DriVive as a transport device to work in conjunction with its newly developed serum serology test for the detection of COVID-19 antibodies. Results are expected late May 2020.
US Patent Issued May 5, 2020 for Plasma Separation Device, Serial Number 16/515,439